Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
The British Journal of Oral & Maxillofacial Surgery|September 11, 2021
COVID-19 associated mucormycosis (CAM) in India: a formidable challengeVishal U S Rao, Gururaj Arakeri, Gaurav Madikeri, et al.Cancers|May 27, 2026
Comment on Rao et al. The Oncological Outcome of Postoperative Radiotherapy in Patients with Node-Negative Early-Stage (T1/T2/N0) Oral Squamous Cell Carcinoma and Perineural Invasion: A Meta-Analysis. <i>Cancers</i> 2025, <i>17</i>, 862Ganesh Datta Borewad, Bhavya Kanakarajulu, Zayba Noor, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|March 13, 2020
Improvement of oral cancer screening quality and reach: The promise of artificial intelligenceAnkita Kar, Volkert B Wreesmann, Vineeth Shwetha, et al.Journal of Toxicology and Environmental Health|March 1, 1996
Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoproteinC L Lanning, R L Fine, C W Sachs, et al.Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|June 21, 2021
Prognostic Significance of Vocal Cord Mobility after Laryngeal Preservation Protocols in Locally Advanced Laryngopharyngeal Cancers: A Retrospective AnalysisVishal U S Rao, Kinjal Shankar Majumdar, Anand Subash, et al.Head & Neck|December 28, 2020
Selective embolization of lingual artery in transoral robotic surgery for the management of recurrent base of tongue carcinomasVishal U S Rao, Anand Subash, Vidya R Bhargavi, et al.Medical Hypotheses|June 7, 2020
COVID-19: Loss of bridging between innate and adaptive immunity?Vishal U S Rao, Gururaj Arakeri, Anand Subash, et al.Molecular Pharmacology|June 1, 1997
P-glycoprotein substrates and antagonists cluster into two distinct groupsS Scala, N Akhmed, U S Rao, et al.Frontiers in Oncology|November 19, 2021
Multidimensional Mutational Profiling of the Indian HNSCC Sub-Population Provides IRAK1, a Novel Driver Gene and Potential Druggable TargetSagar Sanjiv Desai, Raksha Rao K, Anika Jain, et al.Disease-A-Month : DM|March 21, 2022
Decoding the influence of the immune system and immunotherapy targets on carcinomas: A hidden prism in oral cancer therapyVasantha Dhara, Sameep S Shetty, José Alcides Almeida de Arruda, et al.Pageof 5